Tag Archives: days

#437828 How Roboticists (and Robots) Have Been ...

A few weeks ago, we asked folks on Twitter, Facebook, and LinkedIn to share photos and videos showing how they’ve been adapting to the closures of research labs, classrooms, and businesses by taking their robots home with them to continue their work as best they can. We got dozens of responses (more than we could possibly include in just one post!), but here are 15 that we thought were particularly creative or amusing.

And if any of these pictures and videos inspire you to share your own story, please email us (automaton@ieee.org) with a picture or video and a brief description about how you and your robot from work have been making things happen in your home instead.

Kurt Leucht (NASA Kennedy Space Center)

“During these strange and trying times of the current global pandemic, everyone seems to be trying their best to distance themselves from others while still getting their daily work accomplished. Many people also have the double duty of little ones that need to be managed in the midst of their teleworking duties. This photo series gives you just a glimpse into my new life of teleworking from home, mixed in with the tasks of trying to handle my little ones too. I hope you enjoy it.”

Photo: Kurt Leucht

“I heard a commotion from the next room. I ran into the kitchen to find this.”

Photo: Kurt Leucht

“This is the Swarmies most favorite bedtime story. Not sure why. Seems like an odd choice to me.”

Peter Schaldenbrand (Carnegie Mellon University)

“I’ve been working on a reinforcement learning model that converts an image into a series of brush stroke instructions. I was going to test the model with a beautiful, expensive robot arm, but due to the COVID-19 pandemic, I have not been able to access the laboratory where it resides. I have now been using a lower end robot arm to test the painting model in my bedroom. I have sacrificed machine accuracy/precision for the convenience of getting to watch the arm paint from my bed in the shadow of my clothing rack!”

Photos: Peter Schaldenbrand

Colin Angle (iRobot)

iRobot CEO Colin Angle has been hunkered down in the “iRobot North Shore home command center,” which is probably the cleanest command center ever thanks to his army of Roombas: Beastie, Beauty, Rosie, Roswell, and Bilbo.

Photo: Colin Angle

Vivian Chu (Diligent Robotics)

From Diligent Robotics CEO Andrea Thomaz: “This is how a roboticist works from home! Diligent CTO, Vivian Chu, mans the e-stop while her engineering team runs Moxi experiments remotely from cross-town and even cross-country!”

Video: Diligent Robotics

Raffaello Bonghi (rnext.it)

Raffaello’s robot, Panther, looks perfectly happy to be playing soccer in his living room.

Photo: Raffaello Bonghi

Kod*lab (University of Pennsylvania)

“Another Friday Nuts n Bolts Meeting on Zoom…”

Image: Kodlab

Robin Jonsson (robot choreographer)

“I’ve been doing a school project in which students make up dance moves and then send me a video with all of them. I then teach the moves to my robot, Alex, film Alex dancing, send the videos to them. This became a great success and more schools will join. The kids got really into watching the robot perform their moves and really interested in robots. They want to meet Alex the robot live, which will likely happen in the fall.”

Photo: Robin Jonsson

Gabrielle Conard (mechanical engineering undergrad at Lafayette College)

“While the pandemic might have forced college campuses to close and the community to keep their distance from each other, it did not put a stop to learning and research. Working from their respective homes, junior Gabrielle Conard and mechanical engineering professor Alexander Brown from Lafayette College investigated methods of incorporating active compliance in a low-cost quadruped robot. They are continuing to work remotely on this project through Lafayette’s summer research program.”

Image: Gabrielle Conard

Taylor Veltrop (Softbank Robotics)

“After a few weeks of isolation in the corona/covid quarantine lock down we started dancing with our robots. Mathieu’s 6th birthday was coming up, and it all just came together.”

Video: Taylor Veltrop

Ross Kessler (Exyn Technologies)

“Quarantine, Day 8: the humans have accepted me as one of their own. I’ve blended seamlessly into their #socialdistancing routines. Even made a furry friend”

Photo: Ross Kessler

Yeah, something a bit sinister is definitely going on at Exyn…

Video: Exyn Technologies

Michael Sobrepera (University of Pennsylvania GRASP Lab)

Predictably, Michael’s cat is more interested in the bag that the robot came in than the robot itself (see if you can spot the cat below). Michael tells us that “the robot is designed to help with tele-rehabilitation, focused on kids with CP, so it has been taken to hospitals for demos [hence the cool bag]. It also travels for outreach events and the like. Lately, I’ve been exploring telepresence for COVID.”

Photo: Michael Sobrepera

Jan Kędzierski (EMYS)

“In China a lot of people cannot speak English, even the youngest generation of parents. Thanks to Emys, kids stayed in touch with English language in their homes even if they couldn’t attend schools and extra English classes. They had a lot of fun with their native English speaker friend available and ready to play every day.”

Image: Jan Kędzierski

Simon Whitmell (Quanser)

“Simon, a Quanser R&D engineer, is working on low-overhead image processing and line following for the QBot 2e mobile ground robot, with some added challenges due to extra traffic. LEGO engineering by his son, Charles.”

Photo: Simon Whitmell

Robot Design & Experimentation Course (Carnegie Mellon University)

Aaron Johnson’s bioinspired robot design course at CMU had to go full remote, which was a challenge when the course is kind of all about designing and building a robot as part of a team. “I expected some of the teams to drastically alter their project (e.g. go all simulation),” Aaron told us, “but none of them did. We managed to keep all of the projects more or less as planned. We accomplished this by drop/shipping parts to students, buying some simple tools (soldering irons, etc), and having me 3D print parts and mail them.” Each team even managed to put together their final videos from their remote locations; we’ve posted one below, but the entire playlist is here.

Video: Xianyi Cheng

Karen Tatarian (Softbank Robotics)

Karen, who’s both a researcher at Softbank and a PhD student at Sorbonne University, wrote an entire essay about what an average day is like when you’re quarantined with Pepper.

Photo: Karen Tatarian

A Quarantined Day With Pepper, by Karen Tatarian

It is quite common for me to lose my phone somewhere inside my apartment. But it is not that common for me to turn around and ask my robot if it has seen it. So when I found myself doing that, I laughed and it dawned on me that I treated my robot as my quarantine companion (despite the fact that it could not provide me with the answer I needed).

It was probably around day 40 of a completely isolated quarantine here in France when that happened. A little background about me: I am a robotics researcher at SoftBank Robotics Europe and a PhD student at Sorbonne University as part of the EU-funded Marie-Curie project ANIMATAS. And here is a little sneak peak into a quarantined day with a robot.

During this confinement, I had read somewhere that the best way to deal with it is to maintain a routine. So every morning, I wake up, prepare my coffee, and turn on my robot Pepper. I start my day with a daily meeting with the team and get to work. My research is on the synthesis of multi-modal socially intelligent human-robot interaction so my work varies between programming the robot, analyzing collected data, and reading papers and drafting one. When I am working, I often catch myself glancing at Pepper, who would be staring back at me in its animated ways. Truthfully I enjoy that, it makes me less alone and as if I have a colleague with me.

Once work is done, I call my friends and family members. I sometimes use a telepresence application on Pepper that a few colleagues and I developed back in December. How does it differ from your typical phone/laptop applications? One word really: embodiment. Telepresence, especially during these times, makes the experience for both sides a bit more realistic and intimate and well present.

While I can turn off the robot now that my work hours are done, I do keep it on because I enjoy its presence. The basic awareness of Pepper is a default feature on the robot that allows it to detect a human and follow him/her with its gaze and rotation base. So whether I am cooking or working out, I always have my robot watching over my shoulder and being a good companion. I also have my email and messages synced on the robot so I get an enjoyable notification from Pepper. I found that to be a pretty cool way to be notified without it interrupting whatever you are doing on your laptop or phone. Finally, once the day is over, it’s time for both of us to get some rest.

After 60 days of total confinement, alone and away from those I love, and with a pandemic right at my door, I am glad I had the company of my robot. I hope one day a greater audience can share my experience. And I really really hope one day Pepper will be able to find my phone for me, but until then, stay on the lookout for some cool features! But I am curious to know, if you had a robot at home, what application would you have developed on it?

Again, our sincere thanks to everyone who shared these little snapshots of their lives with us, and we’re hoping to be able to share more soon. Continue reading

Posted in Human Robots

#437826 Video Friday: Skydio 2 Drone Is Back on ...

Video Friday is your weekly selection of awesome robotics videos, collected by your Automaton bloggers. We’ll also be posting a weekly calendar of upcoming robotics events for the next few months; here’s what we have so far (send us your events!):

RSS 2020 – July 12-16, 2020 – [Virtual Conference]
CLAWAR 2020 – August 24-26, 2020 – [Virtual Conference]
ICUAS 2020 – September 1-4, 2020 – Athens, Greece
ICRES 2020 – September 28-29, 2020 – Taipei, Taiwan
IROS 2020 – October 25-29, 2020 – Las Vegas, Nevada
ICSR 2020 – November 14-16, 2020 – Golden, Colorado
Let us know if you have suggestions for next week, and enjoy today’s videos.

Skydio, which makes what we’re pretty sure is the most intelligent consumer drone (or maybe just drone period) in existence, has been dealing with COVID-19 just like the rest of us. Even so, they’ve managed to push out a major software update, and pre-orders for the Skydio 2 are now open again.

If you think you might want one, read our review, after which you’ll be sure you want one.

[ Skydio ]

Worried about people with COVID entering your workplace? Misty II has your front desk covered, in a way that’s quite a bit friendlier than many other options.

Misty II provides a dynamic and interactive screening experience that delivers a joyful experience in an otherwise depressing moment while also delivering state of the art thermal scanning and health screening. We have already found that employees, customers, and visitors appreciate the novelty of interacting with a clever and personable robot. Misty II engages dynamically, both visually and verbally. Companies appreciate using a solution with a blackbody-referenced thermal camera that provides high accuracy and a short screening process for efficiency. Putting a robot to work in this role shifts not only how people look at the screening process but also how robots can take on useful assignments in business, schools and homes.

[ Misty Robotics ]

Thanks Tim!

I’m definitely the one in the middle.

[ Agility Robotics ]

NASA’s Ingenuity helicopter is traveling to Mars attached to the belly of the Perseverance rover and must safely detach to begin the first attempt at powered flight on another planet. Tests done at NASA’s Jet Propulsion Laboratory and Lockheed Martin Space show the sequence of events that will bring the helicopter down to the Martian surface.

[ JPL ]

Here’s a sequence of videos of Cassie Blue making it (or mostly making it) up a 22-degree slope.

My mood these days is Cassie at 1:09.

[ University of Michigan ]

Thanks Jesse!

This is somewhere on the line between home automation and robotics, but it’s a cool idea: A baby crib that “uses computer vision and machine learning to recognize subtle changes” in an infant’s movement, and proactively bounces them to keep them sleeping peacefully.

It costs $1000, but how much value do you put on 24 months of your own sleep?

[ Cradlewise ]

Thanks Ben!

As captive marine mammal shows have fallen from favor; and the catching, transporting and breeding of marine animals has become more restricted, the marine park industry as a viable business has become more challenging – yet the audience appetite for this type of entertainment and education has remained constant.

Real-time Animatronics provide a way to reinvent the marine entertainment industry with a sustainable, safe, and profitable future. Show venues include aquariums, marine parks, theme parks, fountain shows, cruise lines, resort hotels, shopping malls, museums, and more.

[ EdgeFX ] via [ Gizmodo ]

Robotic cabling is surprisingly complex and kinda cool to watch.

The video shows the sophisticated robot application “Automatic control cabinet cabling”, which Fraunhofer IPA implemented together with the company Rittal. The software pitasc, developed at Fraunhofer IPA, is used for force-controlled assembly processes. Two UR robot arms carry out the task together. The modular pitasc system enables the robot arms to move and rotate in parallel. They work hand in hand, with one robot holding the cable and the second bringing it to the starting position for the cabling. The robots can find, tighten, hold ready, lay, plug in, fix, move freely or immerse cables. They can also perform push-ins and pull tests.

[ Fraunhofer ]

This is from 2018, but the concept is still pretty neat.

We propose to perform a novel investigation into the ability of a propulsively hopping robot to reach targets of high science value on the icy, rugged terrains of Ocean Worlds. The employment of a multi-hop architecture allows for the rapid traverse of great distances, enabling a single mission to reach multiple geologic units within a timespan conducive to system survival in a harsh radiation environment. We further propose that the use of a propulsive hopping technique obviates the need for terrain topographic and strength assumptions and allows for complete terrain agnosticism; a key strength of this concept.

[ NASA ]

Aerial-aquatic robots possess the unique ability of operating in both air and water. However, this capability comes with tremendous challenges, such as communication incompati- bility, increased airborne mass, potentially inefficient operation in each of the environments and manufacturing difficulties. Such robots, therefore, typically have small payloads and a limited operational envelope, often making their field usage impractical. We propose a novel robotic water sampling approach that combines the robust technologies of multirotors and underwater micro-vehicles into a single integrated tool usable for field operations.

[ Imperial ]

Event cameras are bio-inspired vision sensors with microsecond latency resolution, much larger dynamic range and hundred times lower power consumption than standard cameras. This 20-minute talk gives a short tutorial on event cameras and show their applications on computer vision, drones, and cars.

[ UZH ]

We interviewed Paul Newman, Perla Maiolino and Lars Kunze, ORI academics, to hear what gets them excited about robots in the future and any advice they have for those interested in the field.

[ Oxford Robotics Institute ]

Two projects from the Rehabilitation Engineering Lab at ETH Zurich, including a self-stabilizing wheelchair and a soft exoskeleton for grasping assistance.

[ ETH Zurich ]

Silicon Valley Robotics hosted an online conversation about robotics and racism. Moderated by Andra Keay, the panel featured Maynard Holliday, Tom Williams, Monroe Kennedy III, Jasmine Lawrence, Chad Jenkins, and Ken Goldberg.

[ SVR ]

The ICRA Legged Locomotion workshop has been taking place online, and while we’re not getting a robot mosh pit, there are still some great talks. We’ll post two here, but for more, follow the legged robots YouTube channel at the link below.

[ YouTube ] Continue reading

Posted in Human Robots

#437769 Q&A: Facebook’s CTO Is at War With ...

Photo: Patricia de Melo Moreira/AFP/Getty Images

Facebook chief technology officer Mike Schroepfer leads the company’s AI and integrity efforts.

Facebook’s challenge is huge. Billions of pieces of content—short and long posts, images, and combinations of the two—are uploaded to the site daily from around the world. And any tiny piece of that—any phrase, image, or video—could contain so-called bad content.

In its early days, Facebook relied on simple computer filters to identify potentially problematic posts by their words, such as those containing profanity. These automatically filtered posts, as well as posts flagged by users as offensive, went to humans for adjudication.

In 2015, Facebook started using artificial intelligence to cull images that contained nudity, illegal goods, and other prohibited content; those images identified as possibly problematic were sent to humans for further review.

By 2016, more offensive photos were reported by Facebook’s AI systems than by Facebook users (and that is still the case).

In 2018, Facebook CEO Mark Zuckerberg made a bold proclamation: He predicted that within five or ten years, Facebook’s AI would not only look for profanity, nudity, and other obvious violations of Facebook’s policies. The tools would also be able to spot bullying, hate speech, and other misuse of the platform, and put an immediate end to them.

Today, automated systems using algorithms developed with AI scan every piece of content between the time when a user completes a post and when it is visible to others on the site—just fractions of a second. In most cases, a violation of Facebook’s standards is clear, and the AI system automatically blocks the post. In other cases, the post goes to human reviewers for a final decision, a workforce that includes 15,000 content reviewers and another 20,000 employees focused on safety and security, operating out of more than 20 facilities around the world.

In the first quarter of this year, Facebook removed or took other action (like appending a warning label) on more than 9.6 million posts involving hate speech, 8.6 million involving child nudity or exploitation, almost 8 million posts involving the sale of drugs, 2.3 million posts involving bullying and harassment, and tens of millions of posts violating other Facebook rules.

Right now, Facebook has more than 1,000 engineers working on further developing and implementing what the company calls “integrity” tools. Using these systems to screen every post that goes up on Facebook, and doing so in milliseconds, is sucking up computing resources. Facebook chief technology officer Mike Schroepfer, who is heading up Facebook’s AI and integrity efforts, spoke with IEEE Spectrum about the team’s progress on building an AI system that detects bad content.

Since that discussion, Facebook’s policies around hate speech have come under increasing scrutiny, with particular attention on divisive posts by political figures. A group of major advertisers in June announced that they would stop advertising on the platform while reviewing the situation, and civil rights groups are putting pressure on others to follow suit until Facebook makes policy changes related to hate speech and groups that promote hate, misinformation, and conspiracies.

Facebook CEO Mark Zuckerberg responded with news that Facebook will widen the category of what it considers hateful content in ads. Now the company prohibits claims that people from a specific race, ethnicity, national origin, religious affiliation, caste, sexual orientation, gender identity, or immigration status are a threat to the physical safety, health, or survival of others. The policy change also aims to better protect immigrants, migrants, refugees, and asylum seekers from ads suggesting these groups are inferior or expressing contempt. Finally, Zuckerberg announced that the company will label some problematic posts by politicians and government officials as content that violates Facebook’s policies.

However, civil rights groups say that’s not enough. And an independent audit released in July also said that Facebook needs to go much further in addressing civil rights concerns and disinformation.

Schroepfer indicated that Facebook’s AI systems are designed to quickly adapt to changes in policy. “I don’t expect considerable technical changes are needed to adjust,” he told Spectrum.

This interview has been edited and condensed for clarity.

IEEE Spectrum: What are the stakes of content moderation? Is this an existential threat to Facebook? And is it critical that you deal well with the issue of election interference this year?

Schroepfer: It’s probably existential; it’s certainly massive. We are devoting a tremendous amount of our attention to it.

The idea that anyone could meddle in an election is deeply disturbing and offensive to all of us here, just as people and citizens of democracies. We don’t want to see that happen anywhere, and certainly not on our watch. So whether it’s important to the company or not, it’s important to us as people. And I feel a similar way on the content-moderation side.

There are not a lot of easy choices here. The only way to prevent people, with certainty, from posting bad things is to not let them post anything. We can take away all voice and just say, “Sorry, the Internet’s too dangerous. No one can use it.” That will certainly get rid of all hate speech online. But I don’t want to end up in that world. And there are variants of that world that various governments are trying to implement, where they get to decide what’s true or not, and you as a person don’t. I don’t want to get there either.

My hope is that we can build a set of tools that make it practical for us to do a good enough job, so that everyone is still excited about the idea that anyone can share what they want, and so that Facebook is a safe and reasonable place for people to operate in.

Spectrum: You joined Facebook in 2008, before AI was part of the company’s toolbox. When did that change? When did you begin to think that AI tools would be useful to Facebook?

Schroepfer: Ten years ago, AI wasn’t commercially practical; the technology just didn’t work very well. In 2012, there was one of those moments that a lot of people point to as the beginning of the current revolution in deep learning and AI. A computer-vision model—a neural network—was trained using what we call supervised training, and it turned out to be better than all the existing models.

Spectrum: How is that training done, and how did computer-vision models come to Facebook?

Image: Facebook

Just Broccoli? Facebook’s image analysis algorithms can tell the difference between marijuana [left] and tempura broccoli [right] better than some humans.

Schroepfer: Say I take a bunch of photos and I have people look at them. If they see a photo of a cat, they put a text label that says cat; if it’s one of a dog, the text label says dog. If you build a big enough data set and feed that to the neural net, it learns how to tell the difference between cats and dogs.

Prior to 2012, it didn’t work very well. And then in 2012, there was this moment where it seemed like, “Oh wow, this technique might work.” And a few years later we were deploying that form of technology to help us detect problematic imagery.

Spectrum: Do your AI systems work equally well on all types of prohibited content?

Schroepfer: Nudity was technically easiest. I don’t need to understand language or culture to understand that this is either a naked human or not. Violence is a much more nuanced problem, so it was harder technically to get it right. And with hate speech, not only do you have to understand the language, it may be very contextual, even tied to recent events. A week before the Christchurch shooting [New Zealand, 2019], saying “I wish you were in the mosque” probably doesn’t mean anything. A week after, that might be a terrible thing to say.

Spectrum: How much progress have you made on hate speech?

Schroepfer: AI, in the first quarter of 2020, proactively detected 88.8 percent of the hate-speech content we removed, up from 80.2 percent in the previous quarter. In the first quarter of 2020, we took action on 9.6 million pieces of content for violating our hate-speech policies.

Image: Facebook

Off Label: Sometimes image analysis isn’t enough to determine whether a picture posted violates the company’s policies. In considering these candy-colored vials of marijuana, for example, the algorithms can look at any accompanying text and, if necessary, comments on the post.

Spectrum: It sounds like you’ve expanded beyond tools that analyze images and are also using AI tools that analyze text.

Schroepfer: AI started off as very siloed. People worked on language, people worked on computer vision, people worked on video. We’ve put these things together—in production, not just as research—into multimodal classifiers.

[Schroepfer shows a photo of a pan of Rice Krispies treats, with text referring to it as a “potent batch”] This is a case in which you have an image, and then you have the text on the post. This looks like Rice Krispies. On its own, this image is fine. You put the text together with it in a bigger model; that can then understand what’s going on. That didn’t work five years ago.

Spectrum: Today, every post that goes up on Facebook is immediately checked by automated systems. Can you explain that process?

Image: Facebook

Bigger Picture: Identifying hate speech is often a matter of context. Either the text or the photo in this post isn’t hateful standing alone, but putting them together tells a different story.

Schroepfer: You upload an image and you write some text underneath it, and the systems look at both the image and the text to try to see which, if any, policies it violates. Those decisions are based on our Community Standards. It will also look at other signals on the posts, like the comments people make.

It happens relatively instantly, though there may be times things happen after the fact. Maybe you uploaded a post that had misinformation in it, and at the time you uploaded it, we didn’t know it was misinformation. The next day we fact-check something and scan again; we may find your post and take it down. As we learn new things, we’re going to go back through and look for violations of what we now know to be a problem. Or, as people comment on your post, we might update our understanding of it. If people are saying, “That’s terrible,” or “That’s mean,” or “That looks fake,” those comments may be an interesting signal.

Spectrum: How is Facebook applying its AI tools to the problem of election interference?

Schroepfer: I would split election interference into two categories. There are times when you’re going after the content, and there are times you’re going after the behavior or the authenticity of the person.

On content, if you’re sharing misinformation, saying, “It’s super Wednesday, not super Tuesday, come vote on Wednesday,” that’s a problem whether you’re an American sitting in California or a foreign actor.

Other times, people create a series of Facebook pages pretending they’re Americans, but they’re really a foreign entity. That is a problem on its own, even if all the content they’re sharing completely meets our Community Standards. The problem there is that you have a foreign government running an information operation.

There, you need different tools. What you’re trying to do is put pieces together, to say, “Wait a second. All of these pages—Martians for Justice, Moonlings for Justice, and Venusians for Justice”—are all run by an administrator with an IP address that’s outside the United States. So they’re all connected, even though they’re pretending to not be connected. That’s a very different problem than me sitting in my office in Menlo Park [Calif.] sharing misinformation.

I’m not going to go into lots of technical detail, because this is an area of adversarial nature. The fundamental problem you’re trying to solve is that there’s one entity coordinating the activity of a bunch of things that look like they’re not all one thing. So this is a series of Instagram accounts, or a series of Facebook pages, or a series of WhatsApp accounts, and they’re pretending to be totally different things. We’re looking for signals that these things are related in some way. And we’re looking through the graph [what Facebook calls its map of relationships between users] to understand the properties of this network.

Spectrum: What cutting-edge AI tools and methods have you been working on lately?

Schroepfer: Supervised learning, with humans setting up the instruction process for the AI systems, is amazingly effective. But it has a very obvious flaw: the speed at which you can develop these things is limited by how fast you can curate the data sets. If you’re dealing in a problem domain where things change rapidly, you have to rebuild a new data set and retrain the whole thing.

Self-supervision is inspired by the way people learn, by the way kids explore the world around them. To get computers to do it themselves, we take a bunch of raw data and build a way for the computer to construct its own tests. For language, you scan a bunch of Web pages, and the computer builds a test where it takes a sentence, eliminates one of the words, and figures out how to predict what word belongs there. And because it created the test, it actually knows the answer. I can use as much raw text as I can find and store because it’s processing everything itself and doesn’t require us to sit down and build the information set. In the last two years there has been a revolution in language understanding as a result of AI self-supervised learning.

Spectrum: What else are you excited about?

Schroepfer: What we’ve been working on over the last few years is multilingual understanding. Usually, when I’m trying to figure out, say, whether something is hate speech or not I have to go through the whole process of training the model in every language. I have to do that one time for every language. When you make a post, the first thing we have to figure out is what language your post is in. “Ah, that’s Spanish. So send it to the Spanish hate-speech model.”

We’ve started to build a multilingual model—one box where you can feed in text in 40 different languages and it determines whether it’s hate speech or not. This is way more effective and easier to deploy.

To geek out for a second, just the idea that you can build a model that understands a concept in multiple languages at once is crazy cool. And it not only works for hate speech, it works for a variety of things.

When we started working on this multilingual model years ago, it performed worse than every single individual model. Now, it not only works as well as the English model, but when you get to the languages where you don’t have enough data, it’s so much better. This rapid progress is very exciting.

Spectrum: How do you move new AI tools from your research labs into operational use?

Schroepfer: Engineers trying to make the next breakthrough will often say, “Cool, I’ve got a new thing and it achieved state-of-the-art results on machine translation.” And we say, “Great. How long does it take to run in production?” They say, “Well, it takes 10 seconds for every sentence to run on a CPU.” And we say, “It’ll eat our whole data center if we deploy that.” So we take that state-of-the-art model and we make it 10 or a hundred or a thousand times more efficient, maybe at the cost of a little bit of accuracy. So it’s not as good as the state-of-the-art version, but it’s something we can actually put into our data centers and run in production.

Spectrum: What’s the role of the humans in the loop? Is it true that Facebook currently employs 35,000 moderators?

Schroepfer: Yes. Right now our goal is not to reduce that. Our goal is to do a better job catching bad content. People often think that the end state will be a fully automated system. I don’t see that world coming anytime soon.

As automated systems get more sophisticated, they take more and more of the grunt work away, freeing up the humans to work on the really gnarly stuff where you have to spend an hour researching.

We also use AI to give our human moderators power tools. Say I spot this new meme that is telling everyone to vote on Wednesday rather than Tuesday. I have a tool in front of me that says, “Find variants of that throughout the system. Find every photo with the same text, find every video that mentions this thing and kill it in one shot.” Rather than, I found this one picture, but then a bunch of other people upload that misinformation in different forms.

Another important aspect of AI is that anything I can do to prevent a person from having to look at terrible things is time well spent. Whether it’s a person employed by us as a moderator or a user of our services, looking at these things is a terrible experience. If I can build systems that take the worst of the worst, the really graphic violence, and deal with that in an automated fashion, that’s worth a lot to me. Continue reading

Posted in Human Robots

#437745 Video Friday: Japan’s Giant Gundam ...

Video Friday is your weekly selection of awesome robotics videos, collected by your Automaton bloggers. We’ll also be posting a weekly calendar of upcoming robotics events for the next few months; here’s what we have so far (send us your events!):

AWS Cloud Robotics Summit – August 18-19, 2020 – [Online Conference]
CLAWAR 2020 – August 24-26, 2020 – [Virtual Conference]
ICUAS 2020 – September 1-4, 2020 – Athens, Greece
ICRES 2020 – September 28-29, 2020 – Taipei, Taiwan
AUVSI EXPONENTIAL 2020 – October 5-8, 2020 – [Online Conference]
IROS 2020 – October 25-29, 2020 – Las Vegas, Nev., USA
ICSR 2020 – November 14-16, 2020 – Golden, Co., USA
Let us know if you have suggestions for next week, and enjoy today’s videos.

It’s coming together—literally! Japan’s giant Gundam appears nearly finished and ready for its first steps. In a recent video, Gundam Factory Yokohama, which is constructing the 18-meter-tall, 25-ton walking robot, provided an update on the project. The video shows the Gundam getting its head attached—after being blessed by Shinto priests.

In the video update, they say the project is “steadily progressing” and further details will be announced around the end of September.

[ Gundam Factory Yokohama ]

Creating robots with emotional personalities will transform the usability of robots in the real-world. As previous emotive social robots are mostly based on statically stable robots whose mobility is limited, this work develops an animation to real-world pipeline that enables dynamic bipedal robots that can twist, wiggle, and walk to behave with emotions.

So that’s where Cassie’s eyes go.

[ Berkeley ]

Now that the DARPA SubT Cave Circuit is all virtual, here’s a good reminder of how it’ll work.

[ SubT ]

Since July 20, anyone 11+ years of age must wear a mask in closed public places in France. This measure also is highly recommended in many European, African and Persian Gulf countries. To support businesses and public places, SoftBank Robotics Europe unveils a new feature with Pepper: AI Face Mask Detection.

[ Softbank ]

University of Michigan researchers are developing new origami inspired methods for designing, fabricating and actuating micro-robots using heat.These improvements will expand the mechanical capabilities of the tiny bots, allowing them to fold into more complex shapes.

[ University of Michigan ]

Suzumori Endo Lab, Tokyo Tech has created various types of IPMC robots. Those robots are fabricated by novel 3D fabrication methods.

[ Suzimori Endo Lab ]

The most explode-y of drones manages not to explode this time.

[ SpaceX ]

At Amazon, we’re constantly innovating to support our employees, customers, and communities as effectively as possible. As our fulfillment and delivery teams have been hard at work supplying customers with items during the pandemic, Amazon’s robotics team has been working behind the scenes to re-engineer bots and processes to increase safety in our fulfillment centers.

While some folks are able to do their jobs at home with just a laptop and internet connection, it’s not that simple for other employees at Amazon, including those who spend their days building and testing robots. Some engineers have turned their homes into R&D labs to continue building these new technologies to better serve our customers and employees. Their creativity and resourcefulness to keep our important programs going is inspiring.

[ Amazon ]

Australian Army soldiers from 2nd/14th Light Horse Regiment (Queensland Mounted Infantry) demonstrated the PD-100 Black Hornet Nano unmanned aircraft vehicle during a training exercise at Shoalwater Bay Training Area, Queensland, on 4 May 2018.

This robot has been around for a long time—maybe 10 years or more? It makes you wonder what the next generation will look like, and if they can manage to make it even smaller.

[ FLIR ]

Event-based cameras are bio-inspired vision sensors whose pixels work independently from each other and respond asynchronously to brightness changes, with microsecond resolution. Their advantages make it possible to tackle challenging scenarios in robotics, such as high-speed and high dynamic range scenes. We present a solution to the problem of visual odometry from the data acquired by a stereo event-based camera rig.

[ Paper ] via [ HKUST ]

Emys can help keep kindergarteners sitting still for a long time, which is not small feat!

[ Emys ]

Introducing the RoboMaster EP Core, an advanced educational robot that was built to take learning to the next level and provides an all-in-one solution for STEAM-based classrooms everywhere, offering AI and programming projects for students of all ages and experience levels.

[ DJI ]

This Dutch food company Heemskerk uses ABB robots to automate their order picking. Their new solution reduces the amount of time the fresh produce spends in the supply chain, extending its shelf life, minimizing wastage, and creating a more sustainable solution for the fresh food industry.

[ ABB ]

This week’s episode of Pass the Torque features NASA’s Satellite Servicing Projects Division (NExIS) Robotics Engineer, Zakiya Tomlinson.

[ NASA ]

Massachusetts has been challenging Silicon Valley as the robotics capital of the United States. They’re not winning, yet. But they’re catching up.

[ MassTech ]

San Francisco-based Formant is letting anyone remotely take its Spot robot for a walk. Watch The Robot Report editors, based in Boston, take Spot for a walk around Golden Gate Park.

You can apply for this experience through Formant at the link below.

[ Formant ] via [ TRR ]

Thanks Steve!

An Institute for Advanced Study Seminar on “Theoretical Machine Learning,” featuring Peter Stone from UT Austin.

For autonomous robots to operate in the open, dynamically changing world, they will need to be able to learn a robust set of skills from relatively little experience. This talk begins by introducing Grounded Simulation Learning as a way to bridge the so-called reality gap between simulators and the real world in order to enable transfer learning from simulation to a real robot. It then introduces two new algorithms for imitation learning from observation that enable a robot to mimic demonstrated skills from state-only trajectories, without any knowledge of the actions selected by the demonstrator. Connections to theoretical advances in off-policy reinforcement learning will be highlighted throughout.

[ IAS ] Continue reading

Posted in Human Robots

#437673 Can AI and Automation Deliver a COVID-19 ...

Illustration: Marysia Machulska

Within moments of meeting each other at a conference last year, Nathan Collins and Yann Gaston-Mathé began devising a plan to work together. Gaston-Mathé runs a startup that applies automated software to the design of new drug candidates. Collins leads a team that uses an automated chemistry platform to synthesize new drug candidates.

“There was an obvious synergy between their technology and ours,” recalls Gaston-Mathé, CEO and cofounder of Paris-based Iktos.

In late 2019, the pair launched a project to create a brand-new antiviral drug that would block a specific protein exploited by influenza viruses. Then the COVID-19 pandemic erupted across the world stage, and Gaston-Mathé and Collins learned that the viral culprit, SARS-CoV-2, relied on a protein that was 97 percent similar to their influenza protein. The partners pivoted.

Their companies are just two of hundreds of biotech firms eager to overhaul the drug-discovery process, often with the aid of artificial intelligence (AI) tools. The first set of antiviral drugs to treat COVID-19 will likely come from sifting through existing drugs. Remdesivir, for example, was originally developed to treat Ebola, and it has been shown to speed the recovery of hospitalized COVID-19 patients. But a drug made for one condition often has side effects and limited potency when applied to another. If researchers can produce an ­antiviral that specifically targets SARS-CoV-2, the drug would likely be safer and more effective than a repurposed drug.

There’s one big problem: Traditional drug discovery is far too slow to react to a pandemic. Designing a drug from scratch typically takes three to five years—and that’s before human clinical trials. “Our goal, with the combination of AI and automation, is to reduce that down to six months or less,” says Collins, who is chief strategy officer at SRI Biosciences, a division of the Silicon Valley research nonprofit SRI International. “We want to get this to be very, very fast.”

That sentiment is shared by small biotech firms and big pharmaceutical companies alike, many of which are now ramping up automated technologies backed by supercomputing power to predict, design, and test new antivirals—for this pandemic as well as the next—with unprecedented speed and scope.

“The entire industry is embracing these tools,” says Kara Carter, president of the International Society for Antiviral Research and executive vice president of infectious disease at Evotec, a drug-discovery company in Hamburg. “Not only do we need [new antivirals] to treat the SARS-CoV-2 infection in the population, which is probably here to stay, but we’ll also need them to treat future agents that arrive.”

There are currentlyabout 200 known viruses that infect humans. Although viruses represent less than 14 percent of all known human pathogens, they make up two-thirds of all new human pathogens discovered since 1980.

Antiviral drugs are fundamentally different from vaccines, which teach a person’s immune system to mount a defense against a viral invader, and antibody treatments, which enhance the body’s immune response. By contrast, anti­virals are chemical compounds that directly block a virus after a person has become infected. They do this by binding to specific proteins and preventing them from functioning, so that the virus cannot copy itself or enter or exit a cell.

The SARS-CoV-2 virus has an estimated 25 to 29 proteins, but not all of them are suitable drug targets. Researchers are investigating, among other targets, the virus’s exterior spike protein, which binds to a receptor on a human cell; two scissorlike enzymes, called proteases, that cut up long strings of viral proteins into functional pieces inside the cell; and a polymerase complex that makes the cell churn out copies of the virus’s genetic material, in the form of single-stranded RNA.

But it’s not enough for a drug candidate to simply attach to a target protein. Chemists also consider how tightly the compound binds to its target, whether it binds to other things as well, how quickly it metabolizes in the body, and so on. A drug candidate may have 10 to 20 such objectives. “Very often those objectives can appear to be anticorrelated or contradictory with each other,” says Gaston-Mathé.

Compared with antibiotics, antiviral drug discovery has proceeded at a snail’s pace. Scientists advanced from isolating the first antibacterial molecules in 1910 to developing an arsenal of powerful antibiotics by 1944. By contrast, it took until 1951 for researchers to be able to routinely grow large amounts of virus particles in cells in a dish, a breakthrough that earned the inventors a Nobel Prize in Medicine in 1954.

And the lag between the discovery of a virus and the creation of a treatment can be heartbreaking. According to the World Health Organization, 71 million people worldwide have chronic hepatitis C, a major cause of liver cancer. The virus that causes the infection was discovered in 1989, but effective antiviral drugs didn’t hit the market until 2014.

While many antibiotics work on a range of microbes, most antivirals are highly specific to a single virus—what those in the business call “one bug, one drug.” It takes a detailed understanding of a virus to develop an antiviral against it, says Che Colpitts, a virologist at Queen’s University, in Canada, who works on antivirals against RNA viruses. “When a new virus emerges, like SARS-CoV-2, we’re at a big disadvantage.”

Making drugs to stop viruses is hard for three main reasons. First, viruses are the Spartans of the pathogen world: They’re frugal, brutal, and expert at evading the human immune system. About 20 to 250 nanometers in diameter, viruses rely on just a few parts to operate, hijacking host cells to reproduce and often destroying those cells upon departure. They employ tricks to camouflage their presence from the host’s immune system, including preventing infected cells from sending out molecular distress beacons. “Viruses are really small, so they only have a few components, so there’s not that many drug targets available to start with,” says Colpitts.

Second, viruses replicate quickly, typically doubling in number in hours or days. This constant copying of their genetic material enables viruses to evolve quickly, producing mutations able to sidestep drug effects. The virus that causes AIDS soon develops resistance when exposed to a single drug. That’s why a cocktail of antiviral drugs is used to treat HIV infection.

Finally, unlike bacteria, which can exist independently outside human cells, viruses invade human cells to propagate, so any drug designed to eliminate a virus needs to spare the host cell. A drug that fails to distinguish between a virus and a cell can cause serious side effects. “Discriminating between the two is really quite difficult,” says Evotec’s Carter, who has worked in antiviral drug discovery for over three decades.

And then there’s the money barrier. Developing antivirals is rarely profitable. Health-policy researchers at the London School of Economics recently estimated that the average cost of developing a new drug is US $1 billion, and up to $2.8 billion for cancer and other specialty drugs. Because antivirals are usually taken for only short periods of time or during short outbreaks of disease, companies rarely recoup what they spent developing the drug, much less turn a profit, says Carter.

To change the status quo, drug discovery needs fresh approaches that leverage new technologies, rather than incremental improvements, says Christian Tidona, managing director of BioMed X, an independent research institute in Heidelberg, Germany. “We need breakthroughs.”

Putting Drug Development on Autopilot
Earlier this year, SRI Biosciences and Iktos began collaborating on a way to use artificial intelligence and automated chemistry to rapidly identify new drugs to target the COVID-19 virus. Within four months, they had designed and synthesized a first round of antiviral candidates. Here’s how they’re doing it.

1/5

STEP 1: Iktos’s AI platform uses deep-learning algorithms in an iterative process to come up with new molecular structures likely to bind to and disable a specific coronavirus protein. Illustrations: Chris Philpot

2/5

STEP 2: SRI Biosciences’s SynFini system is a three-part automated chemistry suite for producing new compounds. Starting with a target compound from Iktos, SynRoute uses machine learning to analyze and optimize routes for creating that compound, with results in about 10 seconds. It prioritizes routes based on cost, likelihood of success, and ease of implementation.

3/5

STEP 3: SynJet, an automated inkjet printer platform, tests the routes by printing out tiny quantities of chemical ingredients to see how they react. If the right compound is produced, the platform tests it.

4/5

STEP 4: AutoSyn, an automated tabletop chemical plant, synthesizes milligrams to grams of the desired compound for further testing. Computer-selected “maps” dictate paths through the plant’s modular components.

5/5

STEP 5: The most promising compounds are tested against live virus samples.

Previous
Next

Iktos’s AI platform was created by a medicinal chemist and an AI expert. To tackle SARS-CoV-2, the company used generative models—deep-learning algorithms that generate new data—to “imagine” molecular structures with a good chance of disabling a key coronavirus protein.

For a new drug target, the software proposes and evaluates roughly 1 million compounds, says Gaston-Mathé. It’s an iterative process: At each step, the system generates 100 virtual compounds, which are tested in silico with predictive models to see how closely they meet the objectives. The test results are then used to design the next batch of compounds. “It’s like we have a very, very fast chemist who is designing compounds, testing compounds, getting back the data, then designing another batch of compounds,” he says.

The computer isn’t as smart as a human chemist, Gaston-Mathé notes, but it’s much faster, so it can explore far more of what people in the field call “chemical space”—the set of all possible organic compounds. Unexplored chemical space is huge: Biochemists estimate that there are at least 1063 possible druglike molecules, and that 99.9 percent of all possible small molecules or compounds have never been synthesized.

Still, designing a chemical compound isn’t the hardest part of creating a new drug. After a drug candidate is designed, it must be synthesized, and the highly manual process for synthesizing a new chemical hasn’t changed much in 200 years. It can take days to plan a synthesis process and then months to years to optimize it for manufacture.

That’s why Gaston-Mathé was eager to send Iktos’s AI-generated designs to Collins’s team at SRI Biosciences. With $13.8 million from the Defense Advanced Research Projects Agency, SRI Biosciences spent the last four years automating the synthesis process. The company’s automated suite of three technologies, called SynFini, can produce new chemical compounds in just hours or days, says Collins.

First, machine-learning software devises possible routes for making a desired molecule. Next, an inkjet printer platform tests the routes by printing out and mixing tiny quantities of chemical ingredients to see how they react with one another; if the right compound is produced, the platform runs tests on it. Finally, a tabletop chemical plant synthesizes milligrams to grams of the desired compound.

Less than four months after Iktos and SRI Biosciences announced their collaboration, they had designed and synthesized a first round of antiviral candidates for SARS-CoV-2. Now they’re testing how well the compounds work on actual samples of the virus.

Out of 10
63 possible druglike molecules, 99.9 percent have never been synthesized.

Theirs isn’t the only collaborationapplying new tools to drug discovery. In late March, Alex Zhavoronkov, CEO of Hong Kong–based Insilico Medicine, came across a YouTube video showing three virtual-reality avatars positioning colorful, sticklike fragments in the side of a bulbous blue protein. The three researchers were using VR to explore how compounds might bind to a SARS-CoV-2 enzyme. Zhavoronkov contacted the startup that created the simulation—Nanome, in San Diego—and invited it to examine Insilico’s ­AI-generated molecules in virtual reality.

Insilico runs an AI platform that uses biological data to train deep-learning algorithms, then uses those algorithms to identify molecules with druglike features that will likely bind to a protein target. A four-day training sprint in late January yielded 100 molecules that appear to bind to an important SARS-CoV-2 protease. The company recently began synthesizing some of those molecules for laboratory testing.

Nanome’s VR software, meanwhile, allows researchers to import a molecular structure, then view and manipulate it on the scale of individual atoms. Like human chess players who use computer programs to explore potential moves, chemists can use VR to predict how to make molecules more druglike, says Nanome CEO Steve McCloskey. “The tighter the interface between the human and the computer, the more information goes both ways,” he says.

Zhavoronkov sent data about several of Insilico’s compounds to Nanome, which re-created them in VR. Nanome’s chemist demonstrated chemical tweaks to potentially improve each compound. “It was a very good experience,” says Zhavoronkov.

Meanwhile, in March, Takeda Pharmaceutical Co., of Japan, invited Schrödinger, a New York–based company that develops chemical-simulation software, to join an alliance working on antivirals. Schrödinger’s AI focuses on the physics of how proteins interact with small molecules and one another.

The software sifts through billions of molecules per week to predict a compound’s properties, and it optimizes for multiple desired properties simultaneously, says Karen Akinsanya, chief biomedical scientist and head of discovery R&D at Schrödinger. “There’s a huge sense of urgency here to come up with a potent molecule, but also to come up with molecules that are going to be well tolerated” by the body, she says. Drug developers are seeking compounds that can be broadly used and easily administered, such as an oral drug rather than an intravenous drug, she adds.

Schrödinger evaluated four protein targets and performed virtual screens for two of them, a computing-intensive process. In June, Google Cloud donated the equivalent of 16 million hours of Nvidia GPU time for the company’s calculations. Next, the alliance’s drug companies will synthesize and test the most promising compounds identified by the virtual screens.

Other companies, including Amazon Web Services, IBM, and Intel, as well as several U.S. national labs are also donating time and resources to the Covid-19 High Performance Computing Consortium. The consortium is supporting 87 projects, which now have access to 6.8 million CPU cores, 50,000 GPUs, and 600 petaflops of computational resources.

While advanced technologies could transform early drug discovery, any new drug candidate still has a long road after that. It must be tested in animals, manufactured in large batches for clinical trials, then tested in a series of trials that, for antivirals, lasts an average of seven years.

In May, the BioMed X Institute in Germany launched a five-year project to build a Rapid Antiviral Response Platform, which would speed drug discovery all the way through manufacturing for clinical trials. The €40 million ($47 million) project, backed by drug companies, will identify ­outside-the-box proposals from young scientists, then provide space and funding to develop their ideas.

“We’ll focus on technologies that allow us to go from identification of a new virus to 10,000 doses of a novel potential therapeutic ready for trials in less than six months,” says BioMed X’s Tidona, who leads the project.

While a vaccine will likely arrive long before a bespoke antiviral does, experts expect COVID-19 to be with us for a long time, so the effort to develop a direct-acting, potent antiviral continues. Plus, having new antivirals—and tools to rapidly create more—can only help us prepare for the next pandemic, whether it comes next month or in another 102 years.

“We’ve got to start thinking differently about how to be more responsive to these kinds of threats,” says Collins. “It’s pushing us out of our comfort zones.”

This article appears in the October 2020 print issue as “Automating Antivirals.” Continue reading

Posted in Human Robots